-+ 0.00%
-+ 0.00%
-+ 0.00%

iBio's IBIO-610 Shows 2.3% Lower Body Weight Versus Vehicle in 28-Week Primate Study

PUBT·11/16/2026 21:31:20
Listen to the news
iBio's IBIO-610 Shows 2.3% Lower Body Weight Versus Vehicle in 28-Week Primate Study
  • iBio announced new preclinical results showing its obesity candidate IBIO-610 reduced weight gain in obese monkeys while generally preserving lean mass.
  • Results presented at ObesityWeek on November 15, 2026, also showed reduced body fat and sustained suppression of Activin E.
  • A separate amylin candidate reduced food intake in rats; further preclinical studies in diet-induced obesity models are planned.
  • Amylin findings will be presented at PEGS Europe on November 19, 2026, and the Amylin-Based Therapeutics Summit on December 2, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iBio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611161630PRIMZONEFULLFEED9878814) on November 16, 2026, and is solely responsible for the information contained therein.